| Kalynych, Sergei; Cherney, Maia; Bostina, Mihnea; Rouiller, Isabelle; Cygler, Miroslaw et al. (2014). Quaternary structure of WzzB and WzzE polysaccharide copolymerases. Protein Science 24(1) , 58-69. 10.1002/pro.2586. |
CMCF-ID |
Peer-Reviewed Article |
Health |
| Kalugin, Denis; Bahig, Jumanah; Shoker, Ahmed; Doan, Huu; Kirychuk, Shelley et al. (2024). Superhydrophobic polyether sulfone (PES) dialysis membrane with enhanced hemocompatibility and reduced human serum protein interactions: Ex vivo, in situ synchrotron imaging, experimental, and computational studies. Separation and Purification Technology 335, 126071. 10.1016/j.seppur.2023.126071. |
BMIT-BM |
Peer-Reviewed Article |
Health |
| Kalugin, Denis; Bahig, Jumanah; Shoker, Ahmed; Abdelrasoul, Amira (2023). Heparin-Immobilized Polyethersulfone for Hemocompatibility Enhancement of Dialysis Membrane: In Situ Synchrotron Imaging, Experimental, and Ex Vivo Studies. Membranes 13(8) , 718. 10.3390/membranes13080718. |
BMIT-BM |
Peer-Reviewed Article |
Health |
| Kalliokoski, Tuomo; Kettunen, Henna; Kumpulainen, Esa; Kettunen, Emilia; Thieulin-Pardo, Gabriel et al. (2023). Discovery of novel methionine adenosyltransferase 2A (MAT2A) allosteric inhibitors by structure-based virtual screening. Bioorganic and Medicinal Chemistry Letters 94, 129450. 10.1016/j.bmcl.2023.129450. [PDB: 8p1t, 8p1v] |
CMCF-ID |
Peer-Reviewed Article |
Health |
| Kallander, Lara S.; Washburn, David; Hilfiker, Mark A.; Eidam, Hilary Schenck; Lawhorn, Brian G. et al. (2018). Reverse Hydroxamate Inhibitors of Bone Morphogenetic Protein 1. ACS Medicinal Chemistry Letters 9(7) , 736-740. 10.1021/acsmedchemlett.8b00173. [PDB: 6bsm] |
CMCF-ID |
Peer-Reviewed Article |
Health |
| Kaduk, James; Dosen, Anja; Blanton, Tom (2025). Crystal structure of anisomycin, C
14
H
19
NO
4
. Powder Diffraction , 1-6. 10.1017/s0885715625100791. |
BXDS-WLE |
Peer-Reviewed Article |
Health |
| Kaduk, James A.; Reid, Joel W.; Zhong, Kai; Gindhart, Amy M.; Blanton, Thomas N. et al. (2015). Crystal structure of solifenacin hydrogen succinate, C23H27N2O2(HC4H4O4). Powder Diffraction 30(3) , 1-7. 10.1017/s0885715615000329. |
|
Peer-Reviewed Article |
Health |
| Kaduk, James A.; Dosen, Anja; Blanton, Tom N. (2025). Powder pattern and hydrogen bonding in the crystal structure of phenelzine sulfate, C
8
H
14
N
2
(SO
4
). Powder Diffraction , 1-5. 10.1017/s0885715625000545. |
BXDS-WLE |
Peer-Reviewed Article |
Health |
| Kaduk, James A.; Dosen, Anja; Blanton, Tom N. (2025). Crystal structure of niraparib tosylate monohydrate Form I, (C
19
H
21
N
4
O)(C
7
H
7
O
3
S)(H
2
O). Powder Diffraction , 1-9. 10.1017/s0885715625000181. |
BXDS-WLE |
Peer-Reviewed Article |
Health |
| Kaduk, James A.; Dosen, Anja; Blanton, Tom N. (2025). Crystal structure of ethynodiol diacetate, C
24
H
32
O
4
. Powder Diffraction , 1-6. 10.1017/s0885715625100729. |
BXDS-WLE |
Peer-Reviewed Article |
Health |
| Kaduk, James A.; Dosen, Anja; Blanton, Tom N. (2025). Crystal structure of trametinib dimethyl sulfoxide, C26H23FIN5O4(C2H6OS). Powder Diffraction 40(2) , 162-167. 10.1017/s0885715625000168. |
BXDS-WLE |
Peer-Reviewed Article |
Health |
| Kaduk, James A.; Dosen, Anja; Blanton, Tom N. (2025). Crystal structure of aprocitentan Form A, C16H14Br2N6O4S. Powder Diffraction 40(2) , 168-174. 10.1017/s088571562500017x. |
BXDS-WLE |
Peer-Reviewed Article |
Health |
| Kaduk, James A.; Dosen, Anja; Blanton, Tom (2025). Crystal structure of repotrectinib, C18H18FN5O2. Powder Diffraction , 1-6. 10.1017/s0885715625100882. |
BXDS-WLE |
Peer-Reviewed Article |
Health |
| Kaduk, James A.; Dosen, Anja; Blanton, Tom (2025). Crystal structure of palovarotene, C
27
H
30
N
2
O
2
. Powder Diffraction , 1-6. 10.1017/s0885715625100869. |
BXDS-WLE |
Peer-Reviewed Article |
Health |
| Kaduk, James A.; Dosen, Anja; Blanton, Tom (2025). Crystal structure of givinostat hydrochloride monohydrate Form I, C
24
H
28
N
3
O
4
Cl(H
2
O). Powder Diffraction , 1-6. 10.1017/s0885715625100559. |
BXDS-WLE |
Peer-Reviewed Article |
Health |